This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

HONOLULU (KHON2) — A worker at the Hawaii State Hospital described their work situation as severely short-staffed and dangerous. They said the faulty construction at the new building is just the tip ...

As the war in Ukraine marks its third year, the Ukrainian community in Buffalo is coming together to honor those impacted by ...

The service will no longer be available to new users and current U.K. users will need to eventually disable the security feature, Apple said. The Justice Department is probing diagnoses and practices ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

California legislator introduces bill to prohibit sale of anti-aging skincare products to minors, citing concerns over social ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The House Republicans’ budget blueprint, blessed by Speaker Mike Johnson, has long been stalled in the chamber. On Tuesday, Arrington called for a Thursday committee meeting to resolve vast ...